In an area of telehealth often criticized as a “script factory,” Mochi Health is betting that the real differentiator is the opposite: keeping patients with a provider they trust over the long term.
The advantage of direct-to-consumer telehealth is that it optimizes the transaction. A patient arrives, a questionnaire is processed, a prescription is shipped and the relationship ends, until the next refill or condition sends them back down the funnel.
The model is effective for simple needs but poorly suited to chronic and complex diseases that account for most of the costs and challenges of health care.
Mochi Health, founded by Myra Ahmad in 2022, works on the opposite principle: continuity, not throughput, is what patients actually need and what a telehealth company should be designed for.
Mochi’s stated goal is to keep a patient with the same provider for many needs and over time, an approach that Ahmad says is both better care and a more defensible business.
The continuity problem is supposed to be resolvedAhmad attributes the company to a structural failure she observed in research: patients no longer receiving care because of gaps between specialists.
“Our health system is optimized for billing codes rather than clinical outcomes,” she said. Women of wearables in April 2026.
“Patients move from one specialist to another, but no one seems to ‘own’ their care. When clinicians are paid based on the volume of billable encounters rather than on whether patients improve or continue treatment, nothing in the system rewards keeping a patient connected to a single, accountable relationship.
A single prescription model, however convenient, replicates this gap online. It can deliver medication, but it can’t easily detect treatment failure, adjust a plan as a patient’s situation changes, or coordinate care for different conditions that often combine.
Continuity is the remedy proposed by Mochi. An ongoing relationship that persists between prescriptions rather than resetting with each one.
What continuity looks like on the platformIn practice, Mochi structures care around a chosen provider and ongoing support team rather than a single visit.
Patients choose their own provider and, according to company guidelines siteget unlimited access to a doctor and care team, nutrition coaching with a registered dietitian, in-app messaging, and 24/7 support throughout their journey.
The company believes that care continues well beyond the first prescription, and its members’ testimonials follow the same theme, including that of a patient who said she chose Mochi because she “wanted real support, not just a prescription.”
This continuity is designed to span conditions as well as time. Ahmad said patients can stay with a trusted provider across more than 15 treatment areas and more than 120 conditions, and that expansion beyond weight loss has been driven by patients asking their Mochi providers to handle more of their care.
The destination she describes is a “primary care home,” a unique trusting relationship through which a patient can manage their entire health rather than reassembling it in disconnected practices.
24-hour access to providers, nutritionists and dietitians aims to make this relationship continuous rather than episodic.
Why it’s most important for womenAhmad makes it clear that continuity is not an abstract ideal but a practical necessity. “For women managing their obesity, as well as other health complications such as PCOS, perimenopause or fertility issues, continuity of care is essential,” she said.
A model that keeps a patient with a single provider who understands the big picture is, by design, what good care of these patients was always supposed to look like.
Mochi’s own testimonies echo this point, including one member who said the platform was the first place where his PCOS and GLP-1 journey “was finally taken seriously.”
Business logicA business built on unique prescriptions must continue to acquire patients, an expensive treadmill in a category where marketing costs are high.
A business built on nurtured relationships can grow by deepening them, adding treatment areas as patients request them rather than buying new customers for each one.
Mochi’s expansion from weight loss to dermatology, reproductive health, menopause and longevity follows this logic: Each new area is a reason for an existing patient to stay rather than a new patient to pursue. Retention, in this model, is both the clinical goal and the driver of growth.
The warningsContinuity is easier to promise than to maintain. Mochi’s claims warrant the usual scrutiny. Keeping patients engaged over the long term is difficult for any provider.
Expanding to many conditions also raises the bar: a platform that promises continuity across more than 120 conditions takes on the challenge of maintaining quality and true coordination across all of them, rather than simply offering more crates.
There is a real risk that “continuity” becomes a marketing layer on top of what is still, functionally, a series of prescriptions.
The fairest reading is that Mochi identified a real weakness in transactional telehealth and built its model to address it.
In a field often accused of selling scripts, Mochi is betting that what’s worth selling is the relationship that survives them.
